BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 35462576)

  • 21. Tumor Promoting Role of NRIP1 in Oral Squamous Cell Carcinoma: The Involvement of NSD2-Mediated Histone Methylation of DGCR8.
    Zhang L; Hu G
    Tohoku J Exp Med; 2023 Jul; 260(3):193-204. PubMed ID: 37045786
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Overexpression of nucleostemin contributes to an advanced malignant phenotype and a poor prognosis in oral squamous cell carcinoma.
    Yoshida R; Nakayama H; Nagata M; Hirosue A; Tanaka T; Kawahara K; Nakagawa Y; Matsuoka Y; Sakata J; Arita H; Hiraki A; Shinohara M; Ito T
    Br J Cancer; 2014 Dec; 111(12):2308-15. PubMed ID: 25314067
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long noncoding RNA TFAP2A-AS1 promotes oral squamous cell carcinoma cell growth and movement via competitively binding miR-1297 and regulating TFAP2A expression.
    Yang K; Niu Y; Cui Z; Jin L; Peng S; Dong Z
    Mol Carcinog; 2022 Sep; 61(9):865-875. PubMed ID: 35730908
    [TBL] [Abstract][Full Text] [Related]  

  • 24. High ACTN1 Is Associated with Poor Prognosis, and ACTN1 Silencing Suppresses Cell Proliferation and Metastasis in Oral Squamous Cell Carcinoma.
    Xie GF; Zhao LD; Chen Q; Tang DX; Chen QY; Lu HF; Cai JR; Chen Z
    Drug Des Devel Ther; 2020; 14():1717-1727. PubMed ID: 32440097
    [TBL] [Abstract][Full Text] [Related]  

  • 25. TAF1L promotes development of oral squamous cell carcinoma via decreasing autophagy-dependent apoptosis.
    Wang D; Qi H; Zhang H; Zhou W; Li Y; Li A; Liu Q; Wang Y
    Int J Biol Sci; 2020; 16(7):1180-1193. PubMed ID: 32174793
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Parathyroid hormone-related protein serves as a prognostic indicator in oral squamous cell carcinoma.
    Lv Z; Wu X; Cao W; Shen Z; Wang L; Xie F; Zhang J; Ji T; Yan M; Chen W
    J Exp Clin Cancer Res; 2014 Dec; 33(1):100. PubMed ID: 25539663
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Insulin-like growth factor-independent insulin-like growth factor binding protein 3 promotes cell migration and lymph node metastasis of oral squamous cell carcinoma cells by requirement of integrin β1.
    Yen YC; Hsiao JR; Jiang SS; Chang JS; Wang SH; Shen YY; Chen CH; Chang IS; Chang JY; Chen YW
    Oncotarget; 2015 Dec; 6(39):41837-55. PubMed ID: 26540630
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification of activating transcription factor 6 (ATF6) as a novel prognostic biomarker and potential target in oral squamous cell carcinoma.
    Wu Y; Xie Q; Wu L; Li Z; Li X; Zhang L; Zhang B
    Gene; 2024 Jul; 915():148436. PubMed ID: 38579904
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Down-regulation of lncRNA HCG11 promotes cell proliferation of oral squamous cell carcinoma through sponging miR-455-5p.
    Wu J; Li Y; Liu J; Xu Y
    J Gene Med; 2021 Mar; 23(3):e3293. PubMed ID: 33151000
    [TBL] [Abstract][Full Text] [Related]  

  • 30. SALL4 promotes cancer stem-like cell phenotype and radioresistance in oral squamous cell carcinomas via methyltransferase-like 3-mediated m6A modification.
    Huang J; Li H; Yang Z; Liu R; Li Y; Hu Y; Zhao S; Gao X; Yang X; Wei J
    Cell Death Dis; 2024 Feb; 15(2):139. PubMed ID: 38355684
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Heterotrimeric G-protein alpha-12 (Gα12) subunit promotes oral cancer metastasis.
    Gan CP; Patel V; Mikelis CM; Zain RB; Molinolo AA; Abraham MT; Teo SH; Abdul Rahman ZA; Gutkind JS; Cheong SC
    Oncotarget; 2014 Oct; 5(20):9626-40. PubMed ID: 25275299
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ectopic expression of MELK in oral squamous cell carcinoma and its correlation with epithelial mesenchymal transition.
    Li B; Xu X; Bin X; Zhou J; Tang Z
    Aging (Albany NY); 2021 May; 13(9):13048-13060. PubMed ID: 33962400
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Modulating the ERK1/2-MMP1 Axis through Corosolic Acid Inhibits Metastasis of Human Oral Squamous Cell Carcinoma Cells.
    Chen JL; Lai CY; Ying TH; Lin CW; Wang PH; Yu FJ; Liu CJ; Hsieh YH
    Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445346
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Macrophage migration inhibitory factor is a novel prognostic marker for human oral squamous cell carcinoma.
    Kang Y; Zhang Y; Sun Y
    Pathol Res Pract; 2018 Aug; 214(8):1192-1198. PubMed ID: 30041958
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hypoxia induces TFE3 expression in head and neck squamous cell carcinoma.
    Sun ZJ; Yu GT; Huang CF; Bu LL; Liu JF; Ma SR; Zhang WF; Liu B; Zhang L
    Oncotarget; 2016 Mar; 7(10):11651-63. PubMed ID: 26872381
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CD47-SIRPα Signaling Induces Epithelial-Mesenchymal Transition and Cancer Stemness and Links to a Poor Prognosis in Patients with Oral Squamous Cell Carcinoma.
    Pai S; Bamodu OA; Lin YK; Lin CS; Chu PY; Chien MH; Wang LS; Hsiao M; Yeh CT; Tsai JT
    Cells; 2019 Dec; 8(12):. PubMed ID: 31861233
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MFAP2 promotes the progression of oral squamous cell carcinoma by activating the Wnt/β-catenin signaling pathway through autophagy.
    Zhang H; Shen S; Feng C; Chen G; Wang X
    Acta Biochim Biophys Sin (Shanghai); 2023 Aug; 55(9):1445-1455. PubMed ID: 37592847
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Silencing circular RNA hsa_circ_009755 promotes growth and metastasis of oral squamous cell carcinoma.
    Zhang B; Wang Z; Shen Y; Yang H
    Genomics; 2020 Nov; 112(6):5275-5281. PubMed ID: 32956844
    [TBL] [Abstract][Full Text] [Related]  

  • 39. High expression of Rab31 confers a poor prognosis and enhances cell proliferation and invasion in oral squamous cell carcinoma.
    Li X; Zhu F; Liu Z; Tang X; Han Y; Jiang J; Ma C; He Y
    Oncol Rep; 2021 Mar; 45(3):1182-1192. PubMed ID: 33469675
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Molecular profiling of tumour budding implicates TGFβ-mediated epithelial-mesenchymal transition as a therapeutic target in oral squamous cell carcinoma.
    Jensen DH; Dabelsteen E; Specht L; Fiehn AM; Therkildsen MH; Jønson L; Vikesaa J; Nielsen FC; von Buchwald C
    J Pathol; 2015 Aug; 236(4):505-16. PubMed ID: 25925492
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.